The Committee for Medicinal Products for Human Use adopted a positive opinion for NVS' Kisqali to help reduce the risk of recurrence in people with HR+/HER2- early breast cancer.

Former MTV and BET on-air personality Ananda Lewis shares her journey of Stage IV breast cancer in an exclusive ...

EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...

Novartis' Kisqali receives a positive recommendation from EMA's CHMP for adjuvant treatment of early breast cancer, showing a ...

The European Commission is expected to make a decision on Kisqali's approval in this setting in the next two months.

Novartis on Friday announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing ...

Novartis said the European Medicines Agency has recommended its Kisqali cancer drug for market authorization. The drugmaker said Friday that the EMA's Committee for Medicinal Products for Human Use ...

REGENXBIO Inc. today announced that it will present new interim data evaluating subretinal delivery of ABBV-RGX-314 in ...

Novartis announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion ...

Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing ...

Partly sunny, breezy and cool with spotty rain and mountain snow showers for Wednesday. The best chance for sunshine will be ...

Bank of America Securities analyst Graham Parry reiterated a Hold rating on Novartis AG (NOVN – Research Report) today and set a price ...